Login Get Started
Browse Breadcrumb chevron Shares Breadcrumb chevron Healthcare Breadcrumb chevron Biotechnology & Medical Research Breadcrumb chevron Aprea Therapeutics Inc
Aprea Therapeutics Inc logo

APRE - Aprea Therapeutics Inc News Story

$4.44 -0.0  -0.2%

Last Trade - 14/04/21

Sector
Healthcare
RiskRating
Speculative
Size
Small Cap
Style
Sucker Stock
Market Cap £68.3m
Enterprise Value £3.67m
Revenue £n/a
Position in Universe 5217th / 6854
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions APRE Dividends
All News

BRIEF-Aprea Therapeutics Files For Mixed Shelf Of Upto $350 Mln

Aprea Therapeutics Inc News
Thu 12th November, 2020 10:28pm
Nov 12 (Reuters) - Aprea Therapeutics Inc  APRE.O :
    * APREA THERAPEUTICS - FILES FOR MIXED SHELF OF UPTO $350
MILLION

Source text: (https://bit.ly/35oa8eM)
Further company coverage:  APRE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Aprea Therapeutics Inc

See all news
BRIEF-Aprea Therapeutics Receives FDA Orphan Drug Designation For Eprenetapopt For The Treatment Of Acute Myeloid Leukemia
8th Apr News
BUZZ-Aprea Therapeutics: Jumps on 'orphan drug' tag for cancer treatment
8th Apr News
Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatment of Acute Myeloid Leukemia (AML)
8th Apr News
U.S. RESEARCH ROUNDUP- Comcast, Hershey, Oracle
17th Mar News
BRIEF-Aprea Therapeutics Q4 Loss Per Share $0.73
16th Mar News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.